Zhejiang Dingli Maintained at Neutral: Earnings resilience remains, but demand and tariff visibility are insufficient
AI summary card
Zhejiang Dingli Maintained at Neutral: Earnings resilience remains, but demand and tariff visibility are insufficient
J.P. Morgan slightly raised the target price to Rmb52 and rolled it forward to Jun-27, but maintained a Neutral rating due to weak domestic AWP demand, tariff uncertainty in the US market, and cautious management guidance.
- FY25 revenue was Rmb8.6B, up 10% YoY; NPAT was Rmb1.9B, up 17% YoY, with both revenue and profit reaching record highs.
- About 82% of the company's 2025 sales came from overseas, with a global AWP share of about 10%, but China demand remained weak and US exposure continued to be affected by tariffs and regulatory disruptions.
- FY26E valuation is about 11.6x, which J.P. Morgan believes generally matches earnings growth potential over the forecast period, with a fairly balanced risk-reward profile.
- The target price was slightly raised from Rmb51 to Rmb52 and rolled forward to Jun-27 based on DCF.
Report interpretation
Overview
The report updates the model following Zhejiang Dingli's FY25 earnings call. Year to date, the company's share price has underperformed machinery peers, falling about 10%, while the CSI300 has risen about 3.5%. J.P. Morgan believes Zhejiang Dingli's operating resilience remains relatively strong, with revenue, net profit, and margin quality staying solid, but declining China AWP demand, US tariff uncertainty, and management's reluctance to provide forward guidance leave recovery drivers still unclear.
Core views
The core view is that highlights and pressures coexist. Positives include record-high FY25 revenue and profit, stable gross margin, improved net margin, good expense control, progress in overseas and emerging market expansion, and new product positioning in automation and robotics. Negatives include still-weak procurement from major domestic customers, the impact of tariffs and regulatory changes on the US AWP market, the distorted YoY base from prior early shipments made to cope with tariffs, and limited short-term visibility on demand and earnings. Therefore, the report maintains a Neutral rating.
Analysis framework
The report combines earnings review, management communication, regional demand breakdown, tariff scenario assessment, financial forecast updates, and DCF valuation. The target price is based on DCF and the valuation period is extended to Jun-27; FY26-28E revenue forecasts are basically unchanged, but FY26-28E net profit forecasts are raised by about 6% on average due to more disciplined cost control.
Methodology notes
Target price estimation
The Jun-27 target price of Rmb52 is based on the DCF method, reflecting earnings forecasts, cash flow, and long-term growth assumptions.
Revenue, margin, and cash flow resilience
The report evaluates the company's resilience amid weak demand and tariff disruptions by incorporating FY25 and 4Q25 revenue, net profit, gross margin, net margin, dividend payout ratio, and operating cash flow.
Visibility and valuation alignment
At about 11.6x FY26E, the valuation is viewed by the report as broadly matching earnings growth potential over the forecast period; since recovery drivers remain unclear, the judgment of balanced risk-reward is maintained.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- 603338.SSCovered target in the report
- Strengths
- Global AWP share of about 10%, high overseas revenue mix, record-high FY25 revenue and NPAT, stable gross margin, good expense control, and long-term growth potential from emerging market expansion and new product positioning.
- Weaknesses
- China AWP demand remains weak, the US market is affected by tariff and regulatory uncertainty, management's forward guidance is cautious, and short-term recovery drivers are insufficient.
- Comparison
- Year to date, the share price has fallen about 10%, lagging the CSI300's roughly +3.5% performance; valuation at about 11.6x FY26E is considered broadly in line with earnings growth potential.
- Risks
- Higher tariffs, weaker-than-expected domestic demand recovery, and unfavorable changes in raw material prices, freight rates, and exchange rates could weigh on margins and valuation.
Key data
- Current priceRmb50.89As of April 17, 2026.
- Target priceRmb52.00The target price was slightly raised from Rmb51 and rolled forward to Jun-27.
- RatingNeutralNeutral rating maintained.
- Year-to-date performance-10% vs CSI300 +3.5%The company is one of the weaker-performing stocks among machinery peers.
- FY25 revenueRmb8.6BUp 10% YoY.
- FY25 NPATRmb1.9BUp 17% YoY, a record high.
- FY25 GPM34.3%Overall gross margin was broadly stable.
- FY25 net margin22.1%Up about 1.26 percentage points YoY.
- Dividend payout ratio31%Basically unchanged from FY24.
- Overseas sales mixabout 82%Sales in 2025 mainly came from overseas.
- Global AWP shareabout 10%Indicates strong export exposure.
- FY26E valuation11.6x P/EThe report believes this broadly matches earnings growth potential.
Impact & implications
For investors, the implication is that Zhejiang Dingli has strong capabilities in cost control, product mix optimization, and overseas expansion, but short-term share price re-rating requires clearer recovery in domestic AWP demand, a clearer US tariff path, and delivery of emerging market growth. With the current target price close to the current share price, the report tends to suggest investors wait for clearer recovery catalysts.
Risks
- EU anti-dumping or US sanction-related tariffs may come in higher than expected.
- Recovery in China's domestic AWP demand may be weaker than expected.
- Tariff and regulatory developments in the US market may continue to suppress shipment and earnings visibility.
- Raw material prices, freight rates, or exchange rate trends may move unfavorably.
- Emerging markets have a low base and are still at an early commercialization stage, so growth delivery may be slower than expected.
What to watch
- Whether procurement by major China AWP customers recovers.
- Changes in US tariffs, anti-dumping duty rates, and regulatory policies.
- Order growth in the company's emerging markets in the Middle East, India, Southeast Asia, and Africa.
- Commercialization progress of new automation- and robotics-related products.
- Phase 6 capacity expansion trial production and subsequent capital expenditure discipline.
- Whether cost control and cash flow continue to deliver after upward revisions to FY26-28E profit forecasts.